The short version
10 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Vasostrict
Vasopressin · VASOPRESSIN, UNSPECIFIED 20 [USP'U]/mL · Injection · Intravenous · Par Health USA, LLC
NDC 42023-0164-83 · 25 VIAL in 1 CARTON / 1 mL in 1 VIAL · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$248.00
Reported to Texas DSHS · 2026 annual filing · Par Health USA, LLC
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicare Part B (ASP)
Payment limit per 1 UNIT
$0.490
HCPCS J2598 · Jul 1, 2026 quarter · typically ASP + 6%
Medicaid spend (2023)
$38
15 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA204485
- TE code
- AP
- Approval date
- Apr 17, 2014
- Patents / exclusivity
- 47 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 9375478 | Jan 30, 2035 |
| patent | 9744209 | Jan 30, 2035 |
| patent | 9375478 | Jan 30, 2035 |
| patent | 9937223 | Jan 30, 2035 |
| patent | 9744239 | Jan 30, 2035 |
| patent | 10010575 | Jan 30, 2035 |
| patent | 9981006 | Jan 30, 2035 |
| patent | 9974827 | Jan 30, 2035 |
| patent | 9968649 | Jan 30, 2035 |
| patent | 9962422 | Jan 30, 2035 |
| patent | 9925234 | Jan 30, 2035 |
| patent | 9925233 | Jan 30, 2035 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Vasopressin (Injection)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Eugia US LLC | VASOPRESSIN 20 [USP'U]/mL | Jul 15, 2026 | Sep 3, 2026 |
| HF Acquisition Co LLC, DBA HealthFirst | VASOPRESSIN, UNSPECIFIED 20 [USP'U]/mL | Jul 15, 2026 | Sep 3, 2026 |
| Amneal Pharmaceuticals LLC | VASOPRESSIN 20 [USP'U]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Amphastar Pharmaceuticals, Inc. | VASOPRESSIN 20 [USP'U]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Dr. Reddy's Laboratories, Inc. | VASOPRESSIN, UNSPECIFIED 20 [USP'U]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Gland Pharma Limited | VASOPRESSIN 20 [USP'U]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Gland Pharma Limited | VASOPRESSIN .4 [USP'U]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Medical Purchasin Solutions, LLC | VASOPRESSIN, UNSPECIFIED 20 [USP'U]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Medical Purchasing Solutions, LLC | VASOPRESSIN 20 [USP'U]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Par Health USA, LLC | VASOPRESSIN, UNSPECIFIED .4 [USP'U]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Par Health USA, LLC | VASOPRESSIN, UNSPECIFIED .2 [USP'U]/mL | Jul 15, 2026 | Sep 2, 2026 |
| ProPharma Distribution | VASOPRESSIN 20 [USP'U]/mL | Jul 15, 2026 | Sep 2, 2026 |
| Medical Purchasing Solutions, LLC | VASOPRESSIN, UNSPECIFIED 20 [USP'U]/mL | Jul 15, 2026 | Aug 31, 2026 |
| Par Health USA, LLC | VASOPRESSIN, UNSPECIFIED 20 [USP'U]/mL | Jul 15, 2026 | Aug 28, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Vasostrict — NDC 42023-0164-83," retrieved September 3, 2026, https://drugdashboards.com/drug/42023016483.
Free to cite with attribution — see how the data is put together.